|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/00 | (2006.01) |
| C12N2500/20 | (2013.01) | ||
| C12N 5/0018 | (2013.01) | ||
| C07K2317/41 | (2013.01) | ||
| C12N2510/02 | (2013.01) | ||
| C12N 5/0037 | (2013.01) | ||
| C07K 16/18 | (2013.01) |
| (11) | Number of the document | 3255141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17179340.9 |
| Date of filing the European patent application | 2007-07-11 | |
| (97) | Date of publication of the European application | 2017-12-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 830658 P | 2006-07-13 | US |
| (72) |
Lasko, Daniel R. , US
Koza, Stephan M. , US
|
| (73) |
Wyeth LLC ,
235 East 42nd Street, New York, NY 10017-5755,
US
|
| (54) | PRODUCTION OF ANTIBODIES WITH IMPROVED GLYCOSYLATION PATTERN |
| PRODUCTION OF ANTIBODIES WITH IMPROVED GLYCOSYLATION PATTERN |